The Patient Blood Management market size is USD 15.9 Bn in 2026.
The Patient Blood Management market is projected to grow at a CAGR of 7% by 2033.
The Patient Blood Management market growth is driven by reduced post-operative morbidity, improved chronic disease outcomes, declining mortality rates, and lower donor exposure to infections.
North America is the dominating region for the Patient Blood Management market.
Haemonetics Corporation, Fresenius Kabi, Terumo Corporation, Grifols S.A., and Siemens Healthineers are some leading industry players in the Patient Blood Management market.